Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nvidia Corp (NVDA) vs Tilray Brands Inc (TLRY) Price & Performance

Nvidia CorpTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Nvidia Corp vs Tilray Brands Inc — how do they compare? Nvidia Corp trades at $206.89 (market cap $4.92T), while Tilray Brands Inc trades at $4.27 (market cap $524.07M). The key difference: Nvidia Corp is far larger — about 9388.1× Tilray Brands Inc's market cap, and Nvidia Corp pays a 0.49% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

NVDATLRY
Market Cap
$4.92T$524.07M
Sector
TechnologyHealth
52-Week High
$235.75$21.00
52-Week Low
$165.17$4.23
Enterprise Value
$4.86T$621.22M
Dividend Yield
0.49%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nvidia Corp

Nvidia (NVDA) trades at $207.14, up 2.14% today, with a neutral technical signal and strong fundamental performance. Recent earnings consistently beat estimates, with Q1 2026 EPS of $1.87 exceeding the $1.76 forecast. Revenue surged to $130.50B in 2025, driving a net income margin of 62.97%. The stock faces resistance near $210, while support holds at $201.

Outlook remains positive due to AI-driven growth and robust profitability, but risks include peak AI spending concerns and competitive pressures. Analysts project a $325.86 price target, with 75% recommending Buy. Investors should weigh high valuation multiples against sustained earnings momentum.

Tilray Brands Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Nvidia Corp

NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.

Read more on NVDA

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY